U.S. Outpatient Orthopedic Devices Market: $24.21B by 2035

Market Outlook

By 2035, the U.S. Outpatient Orthopedic Devices Market is expected to reach approximately USD 24.21 billion, expanding at a compound annual growth rate of 8.55% during the forecast period from 2026 to 2035. The market is estimated at USD 10.66 billion in 2025, following growth from USD 7.25 billion in 2021, USD 8.00 billion in 2022, USD 8.87 billion in 2023, and USD 9.74 billion in 2024. Values in this report are expressed in USD billions.

The market value represents estimated manufacturer-level revenue generated from orthopedic implants, procedural devices, surgical instruments, enabling technologies, orthobiologics, braces, supports, and related disposable products used in non-admitted orthopedic care. Covered settings include ambulatory surgery centers, hospital outpatient departments, orthopedic specialty clinics, physician offices, outpatient spine and pain centers, and post-procedure recovery pathways. Facility fees, professional fees, pharmaceuticals, inpatient-only orthopedic device use, and general diagnostic imaging revenue are excluded.

The U.S. outpatient orthopedic devices industry is transitioning from a collection of low-acuity arthroscopy, injection, bracing, and fracture-care products into a high-value procedural ecosystem that increasingly supports total joint replacement, advanced sports medicine, minimally invasive spine surgery, foot and ankle reconstruction, upper-extremity surgery, biologic augmentation, and technology-assisted orthopedic procedures. Clinical progress in anesthesia, blood-loss management, pain control, surgical navigation, implant design, minimally invasive techniques, and postoperative monitoring has widened the range of orthopedic patients who can be discharged without an inpatient admission.

Demand is reinforced by a large and aging U.S. population with osteoarthritis, chronic back pain, sports injuries, degenerative joint disease, osteoporosis-related fractures, and mobility-limiting musculoskeletal conditions. More than 53 million U.S. adults have diagnosed arthritis, while the population aged 65 and older reached approximately 61 million in 2024. These demographic and disease trends support recurring utilization of joint reconstruction implants, arthroscopy systems, fixation devices, spinal implants, orthobiologics, bracing solutions, and postoperative rehabilitation technologies.

The outpatient migration of total knee, total hip, and shoulder replacement is reshaping device procurement. Medicare coverage changes, commercial payer site-of-service policies, improved patient selection, and standardized same-day discharge protocols have made ambulatory orthopedic surgery strategically important to health systems, orthopedic groups, and ASC operators. In 2024, Medicare-certified ambulatory surgery centers recorded particularly strong growth in total knee and total hip arthroplasty volumes, demonstrating that outpatient joint replacement has moved beyond isolated early-adopter programs.

Historical market growth from 2021 through 2024 was supported by the recovery of elective procedures, expanding ASC capacity, deferred orthopedic care returning after the pandemic, and accelerated adoption of sports medicine, extremity, and joint reconstruction products in non-inpatient settings. The 2025 market reflects wider commercialization of ASC-optimized implant portfolios, compact robotic systems, sterile-packed instruments, procedure-specific disposable kits, digital patient-engagement platforms, and contracting models designed around outpatient economics.

Between 2026 and 2035, growth will be determined less by whether procedures can technically be performed on an outpatient basis and more by whether manufacturers can make those procedures operationally predictable. Devices that simplify instrumentation, lower sterilization requirements, shorten turnover time, reduce postoperative complications, support reproducible implant placement, and fit bundled-payment economics will gain preference over products designed primarily around traditional inpatient operating-room workflows.

Introduction

According to the U.S. Outpatient Orthopedic Devices Market Report, the market is shaped by the convergence of musculoskeletal disease burden, aging demographics, surgical innovation, expanding ambulatory infrastructure, payer pressure, and changing orthopedic practice ownership. Orthopedic care is particularly suited to outpatient migration because many procedures are elective, protocol-driven, image-guided, and increasingly supported by regional anesthesia and enhanced recovery pathways.

The market is not limited to devices implanted during same-day joint replacement. It includes a broad range of products used across sports medicine, arthroscopy, fracture fixation, extremity reconstruction, minimally invasive spine surgery, pain intervention, biologic repair, postoperative immobilization, and home-based recovery. Product economics range from relatively low-cost disposable instruments and braces to premium joint implants, spinal constructs, robotic capital systems, navigation platforms, and patient-specific surgical solutions.

Joint reconstruction provides the largest value contribution because hip, knee, and shoulder implants carry comparatively high average selling prices. Sports medicine and arthroscopy contribute substantial recurring consumable demand through sutures, anchors, fixation devices, cannulas, shavers, ablation probes, fluid-management products, and single-use instruments. Trauma and extremity procedures add plates, screws, intramedullary devices, external fixation products, small-joint implants, and procedure-specific instrument kits. Spine and pain procedures contribute interbody devices, fixation systems, biologics, access instruments, vertebral augmentation products, and minimally invasive procedural tools.

The economic structure of outpatient orthopedic care differs materially from inpatient orthopedic surgery. Hospitals can absorb higher capital costs across larger operating-room networks and multiple service lines. Independent and joint-venture ASCs operate within tighter facility reimbursement, limited storage, smaller sterilization departments, and high sensitivity to procedure duration. Device companies therefore need to address the full cost of the procedural episode, including instrument trays, freight, sterilization, staffing, implant waste, rep coverage, operating-room time, and postoperative resource utilization.

A product with a lower acquisition price may not be the most economical choice if it requires multiple trays, extended setup, additional staff, or greater inventory. Conversely, a premium implant or navigation solution may be economically attractive when it supports consistent discharge, reduces revision risk, improves room utilization, or allows a center to complete an additional case during the operating day.

Physician ownership is another defining feature. Orthopedic surgeons often influence both clinical product selection and ASC economics. This creates a procurement environment in which surgeons, administrators, value-analysis teams, and corporate ASC partners jointly evaluate device performance. Manufacturers must demonstrate clinical reliability while also addressing implant pricing, capital financing, tray efficiency, reimbursement, staff training, and utilization thresholds.

The market is also closely linked to the expansion of Medicare-certified ASCs. The U.S. had more than 6,400 such facilities in 2024, and orthopedic specialization was among the fastest-growing ASC categories. Nevertheless, geographic availability remains uneven. Most ASCs are located in urban markets, and outpatient orthopedic access is lower in rural areas where surgical specialists, anesthesia coverage, and postoperative support may be limited.

From 2026 through 2035, the strategic center of the market will move toward integrated outpatient orthopedic platforms. Manufacturers capable of supporting patient selection, preoperative planning, implant delivery, intraoperative execution, sterile workflow, outcomes measurement, and postoperative monitoring will have an advantage over companies offering isolated devices without workflow support.

Key Market Drivers: What Is Fueling the U.S. Outpatient Orthopedic Devices Market?

The first major driver is the continuing migration of orthopedic procedures from inpatient hospitals to outpatient settings. Total knee arthroplasty was removed from Medicare’s inpatient-only list beginning in 2018, followed by total hip arthroplasty in 2020. Medicare subsequently expanded ASC eligibility for these procedures. Total shoulder arthroplasty also entered Medicare ASC reimbursement in 2024. These changes do not make every patient appropriate for outpatient surgery, but they provide a reimbursement foundation for carefully selected patients to receive care outside an inpatient admission.

The shift is now visible in claims activity. Medicare ASC volumes for total knee and total hip arthroplasty increased by more than one-quarter in 2024. Growth of this magnitude supports demand not only for implants but also for cement systems, wound-closure products, disposable instruments, compression devices, navigation technologies, and recovery-support products.

The second driver is the scale of musculoskeletal disease in the U.S. Arthritis affects more than one-fifth of American adults, and prevalence rises sharply with age. Back, lower-limb, and upper-limb pain are also common across the adult population. These conditions create a large continuum of demand extending from conservative bracing and office-based treatment to arthroscopy, fusion, fixation, biologic repair, and joint replacement.

The third driver is demographic aging. The U.S. population aged 65 and older increased to approximately 61.2 million in 2024. Older adults are more likely to experience osteoarthritis, degenerative spine disease, rotator-cuff pathology, fragility fractures, and mobility impairment. This population is also increasingly active and expects treatments that restore function without prolonged hospitalization. Outpatient procedures that reduce disruption, simplify recovery, and lower exposure to hospital environments are therefore gaining acceptance when clinically appropriate.

The fourth driver is the economic advantage of lower-acuity sites of care. Medicare payment rates and beneficiary cost sharing are generally lower in ASCs than in hospital outpatient departments for comparable covered services. Commercial payers also use prior authorization, site-of-service review, bundled payments, and benefit design to direct eligible orthopedic procedures toward lower-cost settings.

For health systems, migrating appropriate cases to ASCs can preserve inpatient capacity for medically complex patients while extending the reach of orthopedic service lines. For orthopedic practices, ASC participation can improve scheduling control, operational consistency, and alignment between clinical and financial decision-making. For patients, outpatient facilities can provide easier scheduling, shorter nonoperative time, and a more specialized care environment.

The fifth driver is the growth of physician-led and corporate ASC networks. Large ASC operators, health systems, private equity-backed orthopedic groups, and payer-affiliated organizations are investing in musculoskeletal facilities. Corporate ownership is increasing the sophistication of procurement. Multi-site operators can aggregate volume, standardize implant vendors, establish national contracting structures, and measure surgeon-level utilization.

This creates opportunity for manufacturers with scalable contracting, dependable logistics, national clinical support, and standardized procedure kits. It also creates pricing pressure because large networks can compare implant costs across facilities and use volume commitments to negotiate lower prices.

The sixth driver is clinical standardization. Enhanced recovery after surgery protocols, regional anesthesia, multimodal pain management, tranexamic acid, blood-conservation strategies, home preparation, preoperative optimization, and structured physical therapy have improved the predictability of same-day discharge. These pathways reduce variation and expand the pool of patients who can complete orthopedic surgery without hospitalization.

Device manufacturers benefit when their products fit standardized protocols. Simplified instrumentation, reproducible surgical steps, low-profile implants, efficient closure products, and digital education tools can reduce workflow variation. Technologies that create unnecessary complexity may struggle even when their clinical performance is acceptable.

The seventh driver is the growth of robotic-assisted and digitally planned orthopedic surgery. Robotic use in total knee arthroplasty has increased substantially, and adoption is spreading from academic hospitals into community hospitals and ASCs. Outpatient facilities favor compact platforms, imageless workflows, limited preoperative imaging requirements, flexible financing, and systems capable of supporting multiple implant configurations.

Robotics can strengthen a manufacturer’s implant franchise by embedding planning software, procedural data, surgeon training, and recurring service relationships into the purchasing decision. The strategic value of the platform may therefore exceed its standalone capital-equipment revenue.

The eighth driver is consumer participation in site-of-care decisions. Patients increasingly compare facilities, surgeon experience, recovery expectations, pricing, and convenience. Employer-sponsored centers of excellence and health-plan navigation programs direct members toward providers that can demonstrate quality and cost performance. Outpatient orthopedic programs with transparent pathways, low complication rates, and reliable patient-reported outcomes are positioned to attract these referrals.

Innovation in Focus: How Manufacturers Are Raising the Bar

Innovation in outpatient orthopedic devices is increasingly measured by the ability to reduce procedural burden. The best-performing technologies are not necessarily those with the most features. They are those that make surgery easier to schedule, staff, execute, and reproduce within a resource-constrained environment.

Compact robotic systems and image-free navigation represent a major innovation area. Traditional robotic systems were designed around large hospital capital budgets and dedicated operating rooms. Newer platforms are being developed with smaller footprints, portable components, simplified registration, and more flexible commercial models. These characteristics are critical for ASCs that may have only a few operating rooms and limited space between cases.

Patient-specific planning is also expanding. Three-dimensional imaging, digital templating, patient-specific guides, customized implants, and biomechanical simulation allow surgeons to plan procedures before the patient enters the operating room. In shoulder, knee, hip, spine, foot, and ankle surgery, patient-specific solutions can help address deformity and anatomical variation. Their commercial success will depend on planning turnaround, manufacturing reliability, reimbursement, and demonstrable reduction in intraoperative complexity.

Sterile-packed implants and reduced-tray systems are becoming important sources of differentiation. Conventional orthopedic procedures can require several instrument trays, each of which must be transported, inspected, sterilized, stored, and prepared. A reduced-tray system can lower reprocessing workload and improve room turnover. Single-use instruments may be attractive for lower-volume procedures, geographically dispersed facilities, or centers without extensive sterile-processing capacity.

Sports medicine innovation is moving toward stronger fixation, smaller implants, biologic preservation, and improved visualization. Knotless anchors, all-suture anchors, adjustable-loop fixation, advanced meniscal repair, cartilage restoration products, and augmented-reality navigation are expanding treatment options. Because sports medicine is already strongly established in ASCs, new products must demonstrate meaningful clinical or workflow advantages rather than rely on the site-of-care shift alone.

Orthobiologic innovation is becoming increasingly relevant to outpatient procedures. Bone graft substitutes, cellular bone matrices, demineralized bone matrix, synthetic graft materials, platelet-rich plasma preparation systems, and soft-tissue augmentation products are used to support fusion and repair. Commercial expansion will depend on evidence quality, regulatory classification, payer coverage, surgeon preference, and clarity regarding product handling.

Minimally invasive spine technologies are being adapted for outpatient environments through smaller incisions, expandable interbody devices, percutaneous fixation, endoscopic access, navigation, and procedure-specific instruments. Appropriate patient selection remains essential because spine cases can involve neurological, anesthetic, and postoperative risks. The most attractive device opportunities are concentrated in procedures with predictable operative duration, controlled blood loss, and limited need for inpatient monitoring.

Digital recovery platforms are becoming part of the device value proposition. Mobile applications, text-based engagement, remote patient monitoring, digital physical therapy, wound surveillance, and patient-reported outcome collection can support the period before and after surgery. Device companies are integrating these tools with implant and robotic platforms to help providers document outcomes and manage larger outpatient patient populations.

Innovation is also occurring in contracting. Subscription models, utilization-based robotics agreements, implant-capital bundles, limited-risk arrangements, and enterprise contracting can lower adoption barriers. These models are particularly relevant to new ASCs that need advanced technology but do not have the capital resources of major hospital systems.

Segmentation Insights

The U.S. Outpatient Orthopedic Devices Market is segmented on the basis of product type, procedure and application, care setting, technology and workflow model, and region.

By Product Type

Joint Reconstruction Implants

Joint reconstruction implants represent the largest product category, accounting for an estimated 34.5% of the market, or approximately USD 3.68 billion in 2025. The segment includes total and partial knee implants, hip implants, shoulder systems, bone cement, fixation components, surgical instruments, and related disposables.

Total knee arthroplasty is the largest outpatient joint reconstruction subsegment because of its high national procedure volume and the maturity of same-day pathways. Total hip arthroplasty is expanding rapidly among healthier patients with reliable home support. Shoulder replacement is a smaller category but is positioned for accelerated growth following Medicare ASC coverage and broader adoption of reverse shoulder arthroplasty.

Demand is moving toward implants and instruments designed for rapid setup, reproducible alignment, soft-tissue preservation, and streamlined discharge. Cementless knee fixation, short-stem hip systems, dual-mobility constructs, and augmented shoulder components are areas of growing interest. Manufacturers must balance innovation with the inventory constraints of outpatient facilities.

Sports Medicine and Arthroscopy Devices

Sports medicine and arthroscopy devices account for approximately 22.0% of the 2025 market, equivalent to nearly USD 2.35 billion. The segment includes suture anchors, interference screws, adjustable-loop fixation, meniscal repair systems, cannulas, shavers, radiofrequency probes, fluid-management products, visualization systems, graft-preparation tools, and cartilage-repair devices.

Shoulder and knee arthroscopy remain the largest applications. Rotator-cuff repair, instability procedures, anterior cruciate ligament reconstruction, meniscal repair, biceps tenodesis, and cartilage treatment generate recurring implant and disposable demand. Hip arthroscopy, elbow procedures, and ankle sports medicine add smaller but faster-growing opportunities.

Sports medicine is highly physician-preference-driven. Product adoption depends on implant handling, fixation strength, procedural simplicity, surgeon training, and sales-representative support. Manufacturers with broad anchor, suture, biologic, visualization, and disposable portfolios can bundle multiple components into a single procedure contract.

Trauma and Extremity Fixation Devices

Trauma and extremity fixation products represent an estimated 17.5% of the market, or approximately USD 1.87 billion in 2025. Products include plates, screws, intramedullary devices, external fixation, compression staples, small-joint implants, fracture-repair instruments, and sterile procedure kits.

A growing share of stable fractures and extremity procedures can be treated through outpatient surgery. Hand, wrist, foot, ankle, clavicle, and selected upper-extremity cases are particularly compatible with ambulatory pathways. Growth is also supported by osteoporosis, falls, active lifestyles, and rising demand for anatomical plating systems.

Foot and ankle is an important strategic subsegment because it remains fragmented and innovation-intensive. Lapidus systems, ankle replacement, hammertoe correction, bunion reconstruction, compression fixation, and patient-specific solutions are attracting investment. The category’s importance was reinforced by recent consolidation involving major orthopedic manufacturers.

Outpatient Spine Devices

Spine devices account for approximately 13.0% of the market, or USD 1.39 billion in 2025. The segment includes interbody devices, fixation systems, cervical implants, bone graft substitutes, vertebral augmentation products, access instruments, and endoscopic spine technologies used in non-admitted procedures.

Anterior cervical discectomy and fusion, lumbar decompression, selected lumbar fusion, sacroiliac joint fusion, vertebral augmentation, and endoscopic decompression are among the procedures increasingly evaluated for outpatient care. Adoption is strongest in specialized facilities with experienced surgeons, standardized anesthesia, and clear escalation pathways.

Spine manufacturers must demonstrate procedural efficiency and predictable postoperative management. Navigation, minimally invasive access, expandable implants, and integrated biologics can improve the value proposition, but complex capital requirements may limit penetration in smaller facilities.

Orthobiologics and Regenerative Products

Orthobiologics contribute approximately 7.0% of market revenue, or USD 0.75 billion in 2025. The category includes bone graft substitutes, demineralized bone matrix, synthetic graft materials, cellular products, platelet-concentrate preparation systems, and soft-tissue augmentation products.

Demand is supported by fusion procedures, tendon repair, cartilage treatment, fracture healing, and revision surgery. However, purchasing decisions are influenced by clinical evidence, reimbursement, product consistency, handling requirements, and regulatory status. Outpatient facilities favor products that are easy to store, prepare, and document.

Bracing, Supports and Recovery Devices

Bracing, immobilization, compression, cold therapy, and recovery-support products represent approximately 6.0% of the market, or USD 0.64 billion in 2025. These devices are used before surgery, immediately after discharge, during rehabilitation, and as alternatives to surgery.

Although average selling prices are lower than those of implants, the segment benefits from high patient volume and recurring replacement demand. Digitally connected bracing, remote adherence tracking, and customized orthoses may create higher-value opportunities.

By Procedure and Application

Total Joint Replacement

Total joint replacement accounts for approximately 36% of 2025 market revenue. Knee and hip procedures dominate, while shoulder replacement is the fastest-expanding major-joint category. Growth depends on patient selection, payer authorization, surgeon comfort, postoperative support, and facility readiness.

The outpatient joint replacement pathway creates demand across the entire episode, including implants, robotics, navigation, wound closure, compression, pain-management accessories, and digital recovery tools. Manufacturers that support the complete pathway can capture more value than implant-only suppliers.

Sports Injury and Soft-Tissue Repair

Sports injury and soft-tissue repair represent approximately 22% of the market. Procedures include rotator-cuff repair, instability correction, ligament reconstruction, meniscal repair, tendon repair, cartilage treatment, and labral reconstruction.

Demand comes from competitive athletes, recreationally active adults, occupational injuries, and age-related tendon degeneration. The segment is expected to retain a strong outpatient orientation throughout the forecast period.

Fracture and Extremity Reconstruction

Fracture and extremity reconstruction represent approximately 17% of the market. Hand, wrist, foot, ankle, elbow, and clavicle procedures are significant ambulatory applications. Aging-related fractures support demand among Medicare patients, while sports and workplace injuries generate commercial-payer volume.

Procedure-specific sterile kits and compact instrument systems are particularly attractive because many extremity cases are lower volume at individual facilities.

Spine and Interventional Musculoskeletal Care

Spine and interventional musculoskeletal procedures account for approximately 15% of market revenue. The category includes outpatient fusion, decompression, vertebral augmentation, sacroiliac procedures, and related implant-intensive interventions.

The segment offers attractive device values but carries higher clinical and regulatory scrutiny. Growth will be concentrated in experienced centers with robust patient screening and transfer arrangements.

Hand, Foot, Ankle and Other Orthopedic Procedures

Other procedures account for approximately 10% of market revenue and include small-joint replacement, bunion correction, hammertoe repair, nerve decompression, hardware removal, tendon procedures, and selected pediatric or deformity corrections.

This category is highly fragmented, creating room for specialized manufacturers with focused portfolios and strong surgeon relationships.

By Care Setting

Ambulatory Surgery Centers

ASCs represent the largest care-setting segment, contributing an estimated 44% of market revenue, or USD 4.69 billion in 2025. Their share is expected to increase through 2035 as joint replacement, shoulder, extremity, and spine procedures continue to migrate.

ASC purchasing emphasizes implant cost, instrument footprint, reprocessing, turnover, scheduling, and service reliability. Manufacturers that cannot meet delivery windows or support multiple facilities may lose contracts even when their devices are clinically competitive.

Hospital Outpatient Departments

Hospital outpatient departments account for approximately 31% of the market, or USD 3.30 billion in 2025. HOPDs remain important for patients requiring greater medical support and for procedures performed within integrated hospital pathways.

Hospitals also use outpatient departments as transition environments before moving mature procedures to freestanding or joint-venture ASCs. Procurement is typically governed by system-level contracting and formal value-analysis processes.

Orthopedic Offices and Specialty Procedure Centers

Orthopedic offices, specialty clinics, and physician-based procedure centers represent approximately 15% of market revenue, or USD 1.60 billion. These sites use braces, biologic preparation systems, injection-support devices, minor surgical instruments, ultrasound-guided procedural products, and postoperative monitoring tools.

Office-based care is important for early intervention, conservative treatment, and long-term management. Device companies that connect office evaluation with surgical planning and recovery can strengthen continuity across the care pathway.

Outpatient Rehabilitation and Home Recovery

Outpatient rehabilitation and home recovery account for approximately 10% of the market, or USD 1.07 billion. The segment includes braces, compression products, cold-therapy systems, range-of-motion devices, remote monitoring, and digital rehabilitation tools.

Growth will be supported by shorter facility stays and increased reliance on home recovery. Products must be simple to deploy, easy for patients to use, and compatible with clinical oversight.

By Technology and Workflow Model

Conventional Implant and Instrument Systems

Conventional implants and reusable instrument systems account for approximately 57% of the market. These products remain essential because of surgeon familiarity, established clinical evidence, and broad reimbursement.

The segment will continue to grow in absolute terms, although its share will gradually decline as digital and patient-specific technologies expand.

Robotic-Assisted Surgery and Navigation

Robotics, navigation, and digital planning contribute approximately 17% of market value. Their share is expected to increase as compact systems, flexible financing, and multi-joint functionality make adoption more practical for outpatient facilities.

Competitive advantage will depend on system footprint, setup time, procedure coverage, implant compatibility, data integration, service responsiveness, and total cost per case.

Patient-Specific and Additively Manufactured Solutions

Patient-specific guides, customized implants, and additive manufacturing represent approximately 9% of the market. These technologies are particularly relevant for anatomical deformity, revision surgery, shoulder reconstruction, foot and ankle procedures, and complex spine cases.

Lead time and supply-chain reliability are critical. Outpatient centers cannot easily absorb procedure cancellations caused by delayed patient-specific products.

Single-Use and Reduced-Tray Systems

Single-use instruments, sterile kits, and reduced-tray systems account for approximately 10% of the market. They can lower reprocessing requirements, reduce contamination risk, and improve operating-room predictability.

Adoption is strongest where procedure volume is insufficient to justify large reusable inventories or where facilities need standardized kits across multiple locations.

Connected and Data-Enabled Orthopedic Devices

Connected recovery devices, digital engagement tools, smart implants, and remote monitoring solutions represent approximately 7% of the market. Revenue remains smaller than implant revenue, but these technologies increasingly influence platform selection.

Providers are seeking tools that collect patient-reported outcomes, identify delayed recovery, and document value. Data interoperability and clinician workflow will determine adoption.

Regional Insights: Where the Market Is Growing Fastest

The U.S. Outpatient Orthopedic Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs according to population growth, age distribution, ASC concentration, orthopedic surgeon density, health-system structure, payer mix, certificate-of-need regulation, employer-sponsored coverage, and availability of postoperative support.

The South is the largest regional market, while the West is expected to record the fastest growth through 2035. The Northeast maintains a high-value procedural base, and the Midwest offers stable demand supported by established orthopedic institutions and mature joint-replacement programs.

South

The South accounted for an estimated USD 4.05 billion in 2025, representing approximately 38.0% of the national market. The region is forecast to reach nearly USD 9.30 billion by 2035, expanding at an estimated CAGR of 8.67%.

The region includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, the District of Columbia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas.

Texas and Florida are the region’s largest state markets. Texas combines rapid population growth, major metropolitan areas, extensive physician-owned healthcare infrastructure, and a large commercial insurance population. Houston, Dallas–Fort Worth, Austin, and San Antonio support high volumes of joint replacement, sports medicine, trauma, spine, and extremity surgery. The state’s size also creates demand for distributed ASC networks and efficient implant logistics.

Florida is particularly important for outpatient joint reconstruction and spinal care because of its large older population. Demand is concentrated around Miami, Fort Lauderdale, Tampa, Orlando, Jacksonville, Naples, Sarasota, and Palm Beach County. Total knee, hip, shoulder, foot and ankle, and spine procedures support substantial implant utilization. The state’s retiree population also sustains demand for braces, mobility products, and postoperative recovery devices.

Georgia has one of the country’s highest concentrations of ASCs per Medicare beneficiary. Recent changes to certificate-of-need rules have also improved development flexibility for selected physician-owned facilities. Atlanta is the central orthopedic market, while Savannah, Augusta, Columbus, and growing suburban areas create additional demand.

North Carolina is positioned for strong growth due to population expansion in Charlotte, Raleigh–Durham, Greensboro, and Wilmington. Changes affecting ASC certificate-of-need requirements in larger counties could support further development. The state has strong academic and community orthopedic programs, making it attractive for robotics, joint replacement, spine, and sports medicine technologies.

Tennessee supports high orthopedic procedure volumes in Nashville, Memphis, Knoxville, and Chattanooga. Nashville’s concentration of healthcare companies and ASC management expertise makes the state strategically relevant to national contracting and facility development.

Virginia and Maryland have sophisticated provider networks and favorable commercial-payer demographics in major metropolitan markets. Maryland has the highest ASC concentration per Medicare beneficiary, supported partly by its all-payer hospital model and incentives to move appropriate care away from hospital departments. This creates a particularly important market for outpatient orthopedic device suppliers.

South Carolina is gaining attractiveness following the removal of several certificate-of-need barriers. Alabama, Mississippi, Louisiana, Kentucky, West Virginia, Arkansas, and Oklahoma have meaningful arthritis, obesity, chronic pain, and mobility impairment burdens. Their demand is concentrated in regional referral centers, but rural access limitations may slow adoption of advanced outpatient surgery.

The South will remain the largest regional opportunity because it combines population scale, Medicare growth, physician entrepreneurship, and expanding ASC infrastructure. Manufacturers must nevertheless account for substantial variation between large metropolitan centers and rural markets.

West

The West represented approximately USD 2.36 billion in 2025, or 22.1% of the market. It is projected to reach approximately USD 5.75 billion by 2035, generating an estimated CAGR of 9.31%, the fastest among the four regions.

The region includes California, Washington, Oregon, Nevada, Arizona, New Mexico, Colorado, Utah, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the largest Western market and one of the most influential outpatient orthopedic markets nationally. Los Angeles, Orange County, San Diego, San Francisco, Sacramento, and the Inland Empire support large orthopedic patient populations and advanced provider networks. The state is an important launch market for robotics, digital care pathways, sports medicine products, patient-specific devices, and minimally invasive technologies.

California’s market is also shaped by large integrated systems, capitated care, workers’ compensation, and sophisticated payer management. Device companies must demonstrate both clinical differentiation and episode-level economics. Independent facilities face high operating costs, making inventory efficiency and instrument reduction particularly valuable.

Arizona has one of the highest ASC concentrations relative to its Medicare population and a rapidly expanding older-adult population. Phoenix, Scottsdale, Tucson, and surrounding communities support strong demand for knee, hip, shoulder, spine, and foot and ankle devices. The state is expected to remain one of the fastest-growing outpatient joint reconstruction markets.

Nevada combines population growth, high ASC availability, and expanding provider capacity in Las Vegas and Reno. Utah, Idaho, and Colorado benefit from younger, active populations as well as growing metropolitan areas. Sports medicine, extremity repair, and outpatient spine procedures are important alongside joint replacement.

Washington and Oregon have mature integrated health systems and strong adoption of value-based care. Procurement decisions tend to emphasize outcomes, evidence, and system compatibility. These states are attractive for digital monitoring, data-enabled recovery, and standardized enterprise platforms.

New Mexico, Montana, Wyoming, and Alaska have low population density and travel-related access challenges. These characteristics create demand for regional hubs, portable equipment, sterile-packed systems, and remote recovery support. Hawaii is geographically isolated, making supply-chain reliability and local inventory management especially important.

The West’s growth will be driven by population movement, technology adoption, sports participation, private orthopedic investment, and demand for digitally integrated care. Manufacturers that can support both high-tech metropolitan facilities and geographically dispersed regional centers will have the strongest positioning.

Northeast

The Northeast accounted for an estimated USD 2.24 billion in 2025, or approximately 21.0% of the national market. It is forecast to reach approximately USD 4.86 billion by 2035, reflecting an estimated CAGR of 8.05%.

The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Maine, New Hampshire, Rhode Island, and Vermont.

New York is the largest Northeast state market. New York City, Long Island, Westchester, Albany, Buffalo, Rochester, and Syracuse support extensive orthopedic volumes. The state has leading academic institutions, specialty hospitals, and complex referral networks. Its outpatient migration is influenced by hospital ownership, regulation, facility costs, and payer contracting.

Pennsylvania provides a large and diverse market across Philadelphia, Pittsburgh, Harrisburg, Allentown, and regional communities. The state supports high joint-replacement, spine, sports medicine, and trauma volumes. Operating-margin data from Pennsylvania ASCs indicate that well-run facilities can produce attractive economics, encouraging continued orthopedic participation.

New Jersey has relatively high ASC availability and a dense insured population. The state is an important market for physician-led orthopedics, joint replacement, spine, and sports medicine. Competitive intensity is high, and manufacturers face strong pricing comparison across neighboring facilities.

Massachusetts is smaller by population but highly influential because of its academic medical centers, specialty hospitals, clinical research infrastructure, and evidence-driven procurement. Innovative technologies may gain early clinical evaluation in Boston before broader national adoption.

Connecticut, Rhode Island, New Hampshire, Maine, and Vermont represent smaller markets. Connecticut has high-income population centers and proximity to New York and Boston. New Hampshire supports ambulatory development in growing southern communities. Maine and Vermont have older populations but lower facility density and greater rural access constraints.

The Northeast will remain a high-value market, although its growth rate is moderated by mature hospital systems, slower population expansion, and regulatory complexity. Premium technologies can succeed when supported by rigorous evidence, outcomes data, and credible economic justification.

Midwest

The Midwest represented approximately USD 2.01 billion in 2025, accounting for 18.9% of the market. The regional market is projected to reach approximately USD 4.30 billion by 2035, expanding at an estimated CAGR of 7.90%.

The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Minnesota, Iowa, Missouri, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the largest Midwestern market, led by Chicago and its surrounding counties. The state has a broad mix of academic hospitals, community systems, physician groups, and ASCs. Demand is strong across joint reconstruction, sports medicine, spine, hand, and foot and ankle procedures.

Ohio has an extensive orthopedic infrastructure across Cleveland, Columbus, Cincinnati, Dayton, and Toledo. Large health systems and specialty practices support high procedural capacity. The state is attractive for enterprise implant contracting and technology-assisted joint replacement.

Michigan contributes substantial knee, hip, spine, and extremity volumes. Detroit, Grand Rapids, Ann Arbor, and other population centers support both academic and community orthopedic care. Indiana has a favorable medical-device and orthopedic manufacturing ecosystem, with strong clinical adoption in Indianapolis, Fort Wayne, and regional markets.

Minnesota is strategically important because of its medtech heritage, research institutions, and orthopedic expertise. Wisconsin supports stable demand through integrated systems and regional networks. Missouri is centered around St. Louis and Kansas City, with meaningful outpatient joint, sports medicine, and spine activity.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller populations but significant rural catchment areas. Outpatient facilities in these states can reduce travel and hospitalization requirements for appropriate patients. However, surgeon availability and transfer capacity remain important constraints.

The Midwest is expected to provide durable growth rather than the highest national CAGR. Manufacturers can succeed through cost-effective contracting, reliable field support, clinical education, and systems that fit community-hospital and regional ASC economics.

Key Market Players

The U.S. Outpatient Orthopedic Devices Competitive Landscape is moderately consolidated in joint reconstruction and spine, while sports medicine, foot and ankle, orthobiologics, bracing, and digital recovery remain more fragmented.

Competition is moving from individual implant selection toward procedural-platform control. Leading companies use robotics, navigation, planning software, implant portfolios, instruments, data services, and contracting structures to strengthen relationships with surgeons and facilities. Specialized companies can gain share by solving a specific outpatient problem, such as tray reduction, patient-specific planning, minimally invasive access, or recovery monitoring.

Some of the key players in the U.S. Outpatient Orthopedic Devices industry are:

Stryker Corporation
Zimmer Biomet Holdings
DePuy Synthes, Johnson & Johnson MedTech
Smith+Nephew
Medtronic
Globus Medical
Arthrex
Enovis Corporation
CONMED Corporation
Integra LifeSciences
Orthofix Medical
Exactech
Alphatec Holdings
ZimVie
Acumed
MicroPort Orthopedics
SI-BONE
Treace Medical Concepts
restor3d
Anika Therapeutics
Bioventus
Össur
Breg
Aspen Medical Products

Stryker, Zimmer Biomet, DePuy Synthes, and Smith+Nephew hold strong positions in joint reconstruction and enabling technologies. Their ability to combine implants with robotics, navigation, instruments, and contracting gives them significant leverage in ASC procurement.

Arthrex and CONMED are important sports medicine and arthroscopy competitors. Arthrex has developed particularly strong surgeon relationships and a broad soft-tissue repair portfolio. Medtronic, Globus Medical, Orthofix, Alphatec, ZimVie, and SI-BONE compete across outpatient spine and related enabling technologies.

Enovis, Acumed, Treace Medical Concepts, restor3d, and the Paragon 28 portfolio within Zimmer Biomet strengthen competition in extremities, foot and ankle, and patient-specific solutions. Bioventus and Anika participate in orthobiologics and joint-preservation categories. Össur, Breg, and Aspen Medical Products are relevant in bracing, immobilization, and postoperative recovery.

Market-share movement will depend on ASC-specific pricing, capital-placement strategy, surgeon conversion, clinical evidence, procedure coverage, sterile-processing efficiency, supply reliability, and the ability to support multi-site customers.

Recent Developments

Recent developments demonstrate that outpatient orthopedics is becoming an established strategic market rather than a secondary sales channel.

Medicare began reimbursing total shoulder arthroplasty in ASCs in 2024. The change widened the addressable market for shoulder implants and associated procedural products. Total knee and hip arthroplasty volumes in Medicare ASCs subsequently recorded strong double-digit growth, confirming continued site-of-care migration.

The expansion of outpatient arthroplasty has increased interest in robotic systems designed for ASCs. Industry disclosures indicate that a meaningful share of certain robotic-system placements is now occurring with ambulatory customers. Compact footprints, imageless workflows, and utilization-linked commercial models are becoming important competitive requirements.

Robotic utilization is also increasing at the procedure level. Registry data indicate that robotic use in total knee arthroplasty reached nearly 16% of reported procedures in 2023, while robotic use in total hip arthroplasty continued to rise. This supports demand for robotic-compatible implants, planning software, service contracts, and data infrastructure.

In April 2025, Zimmer Biomet completed its acquisition of Paragon 28, strengthening its position in the fast-growing foot and ankle market. The transaction illustrates the strategic importance of specialized extremity portfolios as more procedures move to outpatient settings.

Smith+Nephew has continued to expand the capabilities of its CORI robotic platform and has integrated robotic procedure data with analytics and digital recovery solutions. Such combinations reflect the movement toward connected orthopedic pathways rather than isolated capital-equipment sales.

Registry infrastructure is also expanding. The American Joint Replacement Registry now contains data on millions of hip and knee procedures across hospitals, ASCs, and private practices. Greater outcomes visibility will increase pressure on manufacturers and providers to demonstrate implant performance, patient-reported improvement, and low revision rates.

ASC policy remains favorable to continued growth. Medicare extended the use of the hospital market-basket update for ASC payment rates through 2026 while continuing to evaluate procedure migration. Payment policy will remain a critical market variable because facility reimbursement affects the amount available for implants and enabling technology.

Conclusion

The U.S. Outpatient Orthopedic Devices Market is positioned to expand from USD 10.66 billion in 2025 to approximately USD 24.21 billion by 2035, supported by an 8.55% CAGR during the 2026–2035 forecast period.

The market’s growth is grounded in three structural forces: a large population with musculoskeletal disease, a sustained shift toward lower-cost outpatient care, and device innovation that makes complex orthopedic procedures more predictable outside inpatient hospitals.

Joint reconstruction will remain the largest product category, but sports medicine, extremity fixation, outpatient spine, patient-specific devices, and connected recovery technologies will provide meaningful incremental growth. Robotic-assisted surgery and navigation will become increasingly influential, particularly as systems are redesigned around ASC space, staffing, and financing constraints.

The South will remain the largest regional market due to population scale, older-adult growth, physician ownership, and ASC development. The West will grow fastest because of population migration, technology adoption, and expanding orthopedic infrastructure. The Northeast will retain a premium, evidence-driven procedural base, while the Midwest will provide stable demand through established health systems and regional orthopedic networks.

For manufacturers, the central strategic question is no longer whether orthopedic procedures will continue moving to outpatient settings. The more important issue is how to redesign portfolios, contracts, instruments, logistics, and clinical support around the operating model of those settings.

Companies that offer clinically reliable implants without addressing tray burden, turnover, capital cost, facility reimbursement, digital integration, and postoperative recovery will face increasing competitive pressure. Companies that combine differentiated technology with efficient workflow, flexible contracting, dependable supply, and credible outcomes evidence will define the next decade of the U.S. outpatient orthopedic devices industry.

TABLE OF CONTENT

1. U.S. Outpatient Orthopedic Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. Devices Included in the Market Scope
1.2.2. Outpatient Care Settings Included
1.2.3. Revenue and Procedure Boundaries
1.2.4. Market Exclusions
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing and Bottom-Up Procedure Modeling
1.3.6. Average Selling Price and Utilization Analysis
1.3.7. Analytical Frameworks & Forecasting Models
1.3.8. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Orthopedic Implant and Device Manufacturers
1.6.2. Instrument, Component and Contract Manufacturing Suppliers
1.6.3. Ambulatory Surgery Center Operators
1.6.4. Hospital Outpatient Departments and Health Systems
1.6.5. Orthopedic Physician Groups and Specialty Practices
1.6.6. Outpatient Spine and Musculoskeletal Procedure Centers
1.6.7. Rehabilitation and Home-Recovery Providers
1.6.8. Group Purchasing Organizations and Distributors
1.6.9. Commercial Payers, Medicare and Medicaid Programs
1.6.10. FDA, CMS and State Regulatory Authorities
1.6.11. Employers and Centers-of-Excellence Programs
1.7. U.S. Outpatient Orthopedic Care Pathway
1.7.1. Patient Identification and Clinical Evaluation
1.7.2. Conservative Treatment and Preoperative Optimization
1.7.3. Surgical Site-of-Care Selection
1.7.4. Device and Implant Procurement
1.7.5. Same-Day Procedure and Discharge
1.7.6. Postoperative Monitoring and Rehabilitation

What this section provides: This section defines the market boundary, outpatient care settings, covered orthopedic technologies, methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. outpatient orthopedic devices market is measured and validated.

2. U.S. Outpatient Orthopedic Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size and CAGR Summary
2.8. Leading Product Category
2.9. Fastest-Growing Procedure Segment
2.10. Leading Outpatient Care Setting
2.11. Leading Technology and Workflow Model
2.12. Leading Procurement Channel
2.13. Leading and Fastest-Growing Regions
2.14. High-Growth Opportunity Areas
2.14.1. Outpatient Total Knee Arthroplasty
2.14.2. Outpatient Total Hip Arthroplasty
2.14.3. Outpatient Shoulder Replacement
2.14.4. Sports Medicine and Arthroscopic Repair
2.14.5. Minimally Invasive Outpatient Spine Procedures
2.14.6. Robotic-Assisted Orthopedic Surgery
2.14.7. Patient-Specific Implants and Instruments
2.14.8. Sterile-Packed and Reduced-Tray Systems
2.14.9. Connected Recovery and Remote Monitoring

What this section provides: This section gives decision-makers a concise view of market size, growth direction, segment leadership, regional performance, competitive intensity, and priority outpatient orthopedic device opportunities.

3. U.S. Outpatient Orthopedic Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Migration of Orthopedic Procedures to Outpatient Settings
3.1.2. Growth in Medicare-Certified Ambulatory Surgery Centers
3.1.3. Rising Osteoarthritis and Musculoskeletal Disease Burden
3.1.4. Expansion of the U.S. Older-Adult Population
3.1.5. Growth in Outpatient Total Joint Replacement
3.1.6. Expansion of Sports Medicine and Arthroscopy Procedures
3.1.7. Advancement of Minimally Invasive Spine Surgery
3.1.8. Commercial Payer Site-of-Service Optimization
3.1.9. Physician Ownership and Orthopedic ASC Development
3.1.10. Adoption of Enhanced Recovery After Surgery Protocols
3.1.11. Growth in Robotic-Assisted Orthopedic Procedures
3.1.12. Demand for Lower-Cost and High-Throughput Care Models
3.2. Restraints and Their Impact Analysis
3.2.1. High Implant and Enabling-Technology Costs
3.2.2. Restricted ASC Facility Reimbursement
3.2.3. Limited Eligibility of Medically Complex Patients
3.2.4. Capital Budget Constraints Among Independent ASCs
3.2.5. Sterile Processing and Instrument Capacity Limitations
3.2.6. Procedure-Volume Requirements for Technology Adoption
3.2.7. Product Recall, Implant Failure and Litigation Risks
3.2.8. Surgeon Training and Learning-Curve Requirements
3.2.9. Uneven Rural Access to Outpatient Orthopedic Surgery
3.3. Opportunities and Their Impact Analysis
3.3.1. Expansion of Same-Day Knee, Hip and Shoulder Replacement
3.3.2. ASC-Optimized Robotic and Navigation Systems
3.3.3. Patient-Specific and Additively Manufactured Implants
3.3.4. Reduced-Tray and Single-Use Instrument Systems
3.3.5. Advanced Sports Medicine Fixation Technologies
3.3.6. Outpatient Foot and Ankle Reconstruction
3.3.7. Minimally Invasive and Endoscopic Spine Platforms
3.3.8. Orthobiologic Augmentation and Joint Preservation
3.3.9. Digital Patient Engagement and Remote Recovery
3.3.10. Utilization-Based Capital Equipment Models
3.3.11. Employer-Sponsored Orthopedic Centers of Excellence
3.4. Challenges and Their Impact Analysis
3.4.1. Balancing Implant Innovation with ASC Affordability
3.4.2. Managing Device Inventory Across Multi-Site Networks
3.4.3. Maintaining Clinical Support in Distributed Facilities
3.4.4. Standardizing Surgeon Preference Items
3.4.5. Demonstrating Outcomes in Value-Based Care Models
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Outpatient Orthopedic Clinical Workflow Economics Analysis
3.6.1. Procedure-Level Cost Structure
3.6.2. Implant and Disposable Cost Contribution
3.6.3. Operating-Room Time and Turnover Economics
3.6.4. Instrument Tray and Sterilization Economics
3.6.5. Same-Day Discharge and Readmission Economics
3.6.6. Postoperative Rehabilitation Economics
3.7. Orthopedic Capital Procurement Behavior Analysis
3.7.1. Robotic System Acquisition Criteria
3.7.2. Navigation and Digital Planning Investment Criteria
3.7.3. Capital Purchase versus Lease Analysis
3.7.4. Utilization-Based Placement Agreements
3.7.5. Implant-Capital Bundling Models
3.8. Site-of-Care Migration Analysis
3.8.1. Inpatient Hospital to Hospital Outpatient Department
3.8.2. Hospital Outpatient Department to Freestanding ASC
3.8.3. ASC to Office-Based and Specialty Procedure Settings
3.9. Patient Selection and Outpatient Eligibility Analysis

What this section provides: This section explains the clinical, demographic, reimbursement, procurement, and operational forces shaping outpatient orthopedic device demand while identifying growth opportunities and execution risks.

4. U.S. Outpatient Orthopedic Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Outpatient Facility Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.3.1. Joint Reconstruction Implant Pricing
4.3.2. Sports Medicine Device Pricing
4.3.3. Trauma and Extremity Device Pricing
4.3.4. Outpatient Spine Device Pricing
4.3.5. Orthobiologic Pricing
4.3.6. Robotic and Navigation Platform Pricing
4.4. Value Chain & Supply Chain Analysis
4.4.1. Raw Material and Component Supply
4.4.2. Implant and Instrument Manufacturing
4.4.3. Sterilization and Packaging
4.4.4. Distribution and Case Scheduling
4.4.5. Facility-Level Inventory Management
4.4.6. Post-Market Surveillance
4.5. Impact of Digitalization and Connected Orthopedic Care
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. Class I, Class II and Class III Orthopedic Devices
4.7.2. 510(k) Premarket Notification Pathway
4.7.3. Premarket Approval Pathway
4.7.4. De Novo Classification Pathway
4.7.5. Human Cells, Tissues and Cellular Products Considerations
4.7.6. Unique Device Identification Requirements
4.7.7. Post-Market Surveillance and Recall Management
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Medicare ASC Covered Procedures
4.8.2. Hospital Outpatient Prospective Payment System
4.8.3. Inpatient-Only List Changes and Site-of-Care Migration
4.8.4. Device-Intensive Procedure Payment
4.8.5. Commercial Payer Authorization and Site-of-Service Policies
4.8.6. Bundled Payments and Value-Based Orthopedic Care
4.9. State Certificate-of-Need and Facility Licensing Analysis
4.10. Import/Export Restrictions & Tariff Impact
4.11. Government Initiatives and Musculoskeletal Health Programs
4.12. Impact of Escalating Geopolitical Tensions
4.13. Orthopedic Value Analysis Committee Decision Framework
4.13.1. Clinical Evidence Assessment
4.13.2. Implant Price and Procedure Cost Assessment
4.13.3. Instrument and Sterilization Burden
4.13.4. Surgeon Preference and Conversion Risk
4.13.5. Supply Reliability and Vendor Support
4.13.6. Outcomes and Revision Risk
4.14. Environmental Sustainability in Orthopedic Device Procurement
4.14.1. Reusable versus Single-Use Instruments
4.14.2. Packaging Waste Reduction
4.14.3. Sterilization Resource Consumption
4.14.4. Device Reprocessing Considerations

What this section provides: This section gives clients a complete view of regulation, reimbursement, pricing, supply chains, digitalization, state facility rules, sustainability, and outpatient orthopedic procurement dynamics.

5. U.S. Outpatient Orthopedic Devices Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
5.2. Joint Reconstruction Implants
5.2.1. Knee Reconstruction Implants
5.2.1.1. Total Knee Replacement Implants
5.2.1.2. Partial Knee Replacement Implants
5.2.1.3. Cemented Knee Implants
5.2.1.4. Cementless Knee Implants
5.2.1.5. Revision and Augment Components
5.2.2. Hip Reconstruction Implants
5.2.2.1. Total Hip Replacement Implants
5.2.2.2. Femoral Stems
5.2.2.3. Acetabular Cups and Liners
5.2.2.4. Dual-Mobility Systems
5.2.2.5. Short-Stem and Bone-Preserving Systems
5.2.3. Shoulder Reconstruction Implants
5.2.3.1. Anatomic Shoulder Replacement
5.2.3.2. Reverse Shoulder Replacement
5.2.3.3. Humeral and Glenoid Components
5.2.3.4. Stemless Shoulder Systems
5.2.4. Bone Cement and Accessories
5.3. Sports Medicine and Arthroscopy Devices
5.3.1. Suture Anchors
5.3.1.1. Metallic Anchors
5.3.1.2. Biocomposite Anchors
5.3.1.3. All-Suture Anchors
5.3.1.4. Knotless Anchors
5.3.2. Ligament and Tendon Fixation Devices
5.3.3. Meniscal Repair Systems
5.3.4. Arthroscopy Visualization Systems
5.3.5. Shavers and Burrs
5.3.6. Radiofrequency Ablation Devices
5.3.7. Fluid-Management Systems
5.3.8. Cannulas and Access Devices
5.3.9. Cartilage Repair and Restoration Products
5.4. Trauma and Extremity Fixation Devices
5.4.1. Plates and Screws
5.4.2. Intramedullary Fixation Devices
5.4.3. External Fixation Systems
5.4.4. Compression Staples and Nitinol Fixation
5.4.5. Hand and Wrist Implants
5.4.6. Foot and Ankle Implants
5.4.7. Elbow and Upper-Extremity Implants
5.4.8. Small-Joint Replacement Devices
5.4.9. Sterile Trauma Procedure Kits
5.5. Outpatient Spine Devices
5.5.1. Interbody Fusion Devices
5.5.2. Cervical Plates and Fixation Systems
5.5.3. Posterior Fixation Systems
5.5.4. Expandable Interbody Devices
5.5.5. Sacroiliac Joint Fusion Devices
5.5.6. Vertebral Augmentation Devices
5.5.7. Endoscopic Spine Instruments
5.5.8. Minimally Invasive Spine Access Systems
5.6. Orthobiologics and Regenerative Products
5.6.1. Bone Graft Substitutes
5.6.2. Demineralized Bone Matrix
5.6.3. Synthetic Bone Grafts
5.6.4. Cellular Bone Matrices
5.6.5. Platelet-Rich Plasma Preparation Systems
5.6.6. Soft-Tissue Augmentation Products
5.6.7. Cartilage Regeneration Products
5.7. Bracing, Supports and Recovery Devices
5.7.1. Knee Braces and Supports
5.7.2. Hip and Lower-Extremity Supports
5.7.3. Shoulder and Upper-Extremity Braces
5.7.4. Spine Braces and Orthoses
5.7.5. Walking Boots and Fracture Supports
5.7.6. Cold-Therapy and Compression Devices
5.7.7. Range-of-Motion and Rehabilitation Devices

What this section provides: This section identifies the orthopedic device categories and subcategories expected to generate the highest outpatient revenue contribution and strongest growth through 2035.

6. U.S. Outpatient Orthopedic Devices Market – By Procedure and Application

6.1. Overview
6.1.1. Segment Share Analysis, By Procedure and Application, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
6.2. Total Joint Replacement
6.2.1. Total Knee Arthroplasty
6.2.2. Partial Knee Arthroplasty
6.2.3. Total Hip Arthroplasty
6.2.4. Total Shoulder Arthroplasty
6.2.5. Reverse Shoulder Arthroplasty
6.2.6. Selected Revision Joint Procedures
6.3. Sports Injury and Soft-Tissue Repair
6.3.1. Rotator-Cuff Repair
6.3.2. Shoulder Instability Repair
6.3.3. Anterior Cruciate Ligament Reconstruction
6.3.4. Meniscal Repair
6.3.5. Hip Arthroscopy and Labral Repair
6.3.6. Tendon Repair
6.3.7. Cartilage Restoration
6.3.8. Biceps Tenodesis
6.4. Fracture and Extremity Reconstruction
6.4.1. Hand and Wrist Fracture Repair
6.4.2. Foot and Ankle Reconstruction
6.4.3. Clavicle and Shoulder-Girdle Fixation
6.4.4. Elbow and Forearm Reconstruction
6.4.5. Small-Joint Reconstruction
6.4.6. Hardware Removal and Revision
6.5. Spine and Interventional Musculoskeletal Care
6.5.1. Anterior Cervical Discectomy and Fusion
6.5.2. Lumbar Decompression
6.5.3. Selected Lumbar Fusion Procedures
6.5.4. Endoscopic Spine Procedures
6.5.5. Sacroiliac Joint Fusion
6.5.6. Vertebral Augmentation
6.5.7. Peripheral Nerve Decompression
6.6. Hand, Foot, Ankle and Other Orthopedic Procedures
6.6.1. Carpal Tunnel Release
6.6.2. Trigger Finger Release
6.6.3. Bunion Correction
6.6.4. Hammertoe Repair
6.6.5. Ankle Stabilization
6.6.6. Tendon Reconstruction
6.6.7. Small-Joint Arthroplasty
6.7. Orthopedic Pain Management and Joint Preservation
6.7.1. Biologic Injection Procedures
6.7.2. Cartilage-Preservation Procedures
6.7.3. Vertebral Compression Fracture Treatment
6.7.4. Minimally Invasive Musculoskeletal Intervention

What this section provides: This section helps clients prioritize outpatient orthopedic procedures according to implant intensity, procedure growth, reimbursement viability, clinical complexity, and technology adoption.

7. U.S. Outpatient Orthopedic Devices Market – By Care Setting

7.1. Overview
7.1.1. Segment Share Analysis, By Care Setting, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
7.2. Freestanding Ambulatory Surgery Centers
7.2.1. Independent Physician-Owned ASCs
7.2.2. Hospital–Physician Joint-Venture ASCs
7.2.3. Corporate ASC Network Facilities
7.2.4. Orthopedic Specialty ASCs
7.2.5. Multispecialty ASCs with Orthopedic Service Lines
7.3. Hospital Outpatient Departments
7.3.1. Academic Medical Center Outpatient Departments
7.3.2. Community Hospital Outpatient Departments
7.3.3. Hospital-Owned Orthopedic Specialty Facilities
7.3.4. Hospital Satellite Surgery Centers
7.4. Orthopedic Offices and Specialty Procedure Centers
7.4.1. Orthopedic Group Practices
7.4.2. Sports Medicine Clinics
7.4.3. Office-Based Procedure Suites
7.4.4. Foot and Ankle Specialty Practices
7.4.5. Hand and Upper-Extremity Specialty Practices
7.5. Outpatient Spine and Pain Centers
7.5.1. Spine Specialty Surgery Centers
7.5.2. Interventional Musculoskeletal Centers
7.5.3. Minimally Invasive Spine Facilities
7.6. Outpatient Rehabilitation and Home Recovery
7.6.1. Physical Therapy and Rehabilitation Centers
7.6.2. Home-Based Recovery Programs
7.6.3. Remote Monitoring Providers
7.6.4. Durable Medical Equipment Providers

What this section provides: This section explains which outpatient care environments are expected to drive orthopedic device purchasing, procedure migration, capital adoption, and post-discharge recovery demand.

8. U.S. Outpatient Orthopedic Devices Market – By Technology and Workflow Model

8.1. Overview
8.1.1. Segment Share Analysis, By Technology and Workflow Model, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
8.2. Conventional Implant and Reusable Instrument Systems
8.2.1. Standard Manual Instrumentation
8.2.2. Reusable Implant Instrument Trays
8.2.3. Conventional Arthroscopy Systems
8.2.4. Standard Trauma and Spine Systems
8.3. Robotic-Assisted Surgery and Navigation
8.3.1. Robotic Knee Surgery Systems
8.3.2. Robotic Hip Surgery Systems
8.3.3. Robotic Shoulder Surgery Systems
8.3.4. Robotic Spine Surgery Systems
8.3.5. Computer-Assisted Navigation
8.3.6. Imageless Navigation
8.3.7. Portable and Compact ASC Robotic Systems
8.4. Patient-Specific and Additively Manufactured Solutions
8.4.1. Patient-Specific Cutting Guides
8.4.2. Patient-Specific Instrumentation
8.4.3. Customized Joint Implants
8.4.4. Customized Extremity Implants
8.4.5. Additively Manufactured Spine Implants
8.4.6. Three-Dimensional Surgical Planning
8.5. Single-Use and Reduced-Tray Systems
8.5.1. Sterile-Packed Implants
8.5.2. Single-Use Instruments
8.5.3. Procedure-Specific Sterile Kits
8.5.4. Reduced-Tray Joint Systems
8.5.5. Reduced-Tray Trauma and Extremity Systems
8.6. Connected and Data-Enabled Orthopedic Technologies
8.6.1. Digital Preoperative Planning
8.6.2. AI-Assisted Surgical Planning
8.6.3. Smart and Sensor-Enabled Implants
8.6.4. Remote Patient Monitoring
8.6.5. Digital Physical Therapy Platforms
8.6.6. Patient-Reported Outcome Platforms
8.6.7. Cloud-Based Robotic and Procedure Analytics

What this section provides: This section evaluates the technology platforms reshaping outpatient orthopedics, including conventional systems, robotics, patient-specific solutions, sterile workflow technologies, artificial intelligence, and connected recovery.

9. U.S. Outpatient Orthopedic Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
9.2. Direct ASC and Orthopedic Group Procurement
9.2.1. Independent ASC Contracting
9.2.2. Physician-Owned Facility Contracting
9.2.3. Multi-Site Orthopedic Group Contracting
9.2.4. Surgeon Preference-Based Purchasing
9.3. Hospital and Integrated Delivery Network Outpatient Contracts
9.3.1. Enterprise Implant Agreements
9.3.2. Hospital–ASC Standardization Contracts
9.3.3. Health System Capital Procurement
9.3.4. Value Analysis Committee Procurement
9.4. Group Purchasing Organization Contracts
9.4.1. National GPO Agreements
9.4.2. Regional GPO Agreements
9.4.3. ASC-Focused Purchasing Networks
9.4.4. Committed-Volume Agreements
9.5. Distributor and Specialty Supplier Sales
9.5.1. Orthopedic Specialty Distributors
9.5.2. Independent Sales Agencies
9.5.3. Durable Medical Equipment Distributors
9.5.4. Regional Implant and Instrument Logistics Providers
9.6. Capital Equipment and Technology Procurement Models
9.6.1. Direct Capital Purchase
9.6.2. Operating Lease
9.6.3. Utilization-Based Placement
9.6.4. Implant-Capital Bundling
9.6.5. Subscription and Service Agreements
9.6.6. Per-Procedure Technology Fees

What this section provides: This section explains how outpatient orthopedic devices and enabling technologies are purchased through physician groups, ASCs, health systems, GPOs, distributors, and flexible capital-placement models.

10. U.S. Outpatient Orthopedic Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Outpatient Orthopedic Procedure Volume Analysis
10.1.4. Regional ASC and Hospital Outpatient Infrastructure Analysis
10.1.5. Regional Orthopedic Surgeon and Specialty Practice Density
10.1.6. Regional Medicare and Commercial Payer Mix
10.1.7. Regional Reimbursement and Site-of-Care Dynamics
10.1.8. Regional Procurement and Contracting Dynamics
10.1.9. State Certificate-of-Need and Facility Development Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Outpatient Orthopedic Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Outpatient Orthopedic Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Outpatient Orthopedic Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.24. Delaware
10.4.24.1. Overview
10.4.24.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.24.3. Delaware Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.24.4. Delaware Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.24.5. Delaware Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.24.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.25. District of Columbia
10.4.25.1. Overview
10.4.25.2. District of Columbia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.25.3. District of Columbia Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.4.25.4. District of Columbia Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.4.25.5. District of Columbia Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.4.25.6. District of Columbia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Outpatient Orthopedic Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Procedure and Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Care Setting, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology and Workflow Model, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis across all 50 states and the District of Columbia, helping clients identify orthopedic procedure hubs, ASC expansion markets, technology-adoption hotspots, and state-level commercial opportunities.

11. U.S. Outpatient Orthopedic Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.1.1. Market Share by Overall Outpatient Orthopedic Device Revenue
11.1.2. Market Share by Joint Reconstruction
11.1.3. Market Share by Sports Medicine and Arthroscopy
11.1.4. Market Share by Trauma and Extremities
11.1.5. Market Share by Outpatient Spine
11.1.6. Market Share by Robotics and Navigation
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking
11.3.1. Product Portfolio Breadth
11.3.2. ASC-Specific Commercial Strategy
11.3.3. Robotic and Digital Capabilities
11.3.4. Surgeon Training Infrastructure
11.3.5. Clinical Evidence Strength
11.3.6. Distribution and Case-Support Capabilities
11.3.7. Pricing and Contracting Flexibility
11.3.8. Recent Mergers, Acquisitions and Partnerships
11.4. Company Profiles
11.4.1. Stryker Corporation
11.4.2. Zimmer Biomet Holdings
11.4.3. DePuy Synthes, Johnson & Johnson MedTech
11.4.4. Smith+Nephew
11.4.5. Arthrex
11.4.6. Medtronic
11.4.7. Globus Medical
11.4.8. Enovis Corporation
11.4.9. CONMED Corporation
11.4.10. Integra LifeSciences
11.4.11. Orthofix Medical
11.4.12. Exactech
11.4.13. Alphatec Holdings
11.4.14. ZimVie
11.4.15. Acumed
11.4.16. MicroPort Orthopedics
11.4.17. SI-BONE
11.4.18. Treace Medical Concepts
11.4.19. restor3d
11.4.20. Anika Therapeutics
11.4.21. Bioventus
11.4.22. Össur
11.4.23. Breg
11.4.24. Aspen Medical Products
11.4.25. OrthoPediatrics

Note: Each company profile will include company overview, outpatient orthopedic device portfolio, key products, U.S. commercial strategy, ASC positioning, financial performance, robotic and digital capabilities, regulatory updates, clinical evidence, partnerships, acquisitions, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, ASC strategy, innovation direction, and strategic intelligence on 25 major outpatient orthopedic device companies.

12. U.S. Outpatient Orthopedic Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Compact ASC Robotic Systems
12.2.2. Artificial Intelligence-Assisted Surgical Planning
12.2.3. Patient-Specific and Customized Implants
12.2.4. Additively Manufactured Orthopedic Devices
12.2.5. Smart and Sensor-Enabled Implants
12.2.6. Single-Use and Reduced-Tray Procedure Systems
12.2.7. Endoscopic and Minimally Invasive Spine Technologies
12.2.8. Digital Recovery and Remote Monitoring Platforms
12.2.9. Advanced Orthobiologics and Regenerative Technologies
12.3. Emerging Business Trends
12.3.1. Physician Practice Consolidation
12.3.2. Growth of National Orthopedic ASC Networks
12.3.3. Hospital–Physician Joint Ventures
12.3.4. Private Equity Investment in Orthopedic Platforms
12.3.5. Employer Centers-of-Excellence Contracting
12.3.6. Implant and Capital Equipment Bundling
12.3.7. Outcomes-Based and Risk-Sharing Contracts
12.4. Business Opportunities for Startups and Existing Players
12.4.1. ASC Workflow Optimization
12.4.2. Sterile-Packed Procedure Solutions
12.4.3. Remote Postoperative Monitoring
12.4.4. Patient-Specific Extremity Reconstruction
12.4.5. Digital Surgical Planning
12.4.6. Outpatient Spine Technologies
12.4.7. Orthopedic Data and Outcomes Analytics
12.5. Investment Prioritization Matrix
12.5.1. Market Attractiveness
12.5.2. Clinical Differentiation
12.5.3. Reimbursement Viability
12.5.4. Capital Intensity
12.5.5. Competitive Intensity
12.5.6. Scalability Across Outpatient Settings
12.6. Forecast Sensitivity Analysis
12.6.1. Procedure Migration Sensitivity
12.6.2. Implant Pricing Sensitivity
12.6.3. Medicare Reimbursement Sensitivity
12.6.4. Robotic Adoption Sensitivity
12.6.5. ASC Development Sensitivity

What this section provides: This section prepares clients for technology disruption, procedure migration, market-structure changes, investment opportunities, and alternative adoption scenarios through 2035.

13. U.S. Outpatient Orthopedic Devices Market: Strategic Recommendations

13.1. Recommendations for Orthopedic Device Manufacturers
13.1.1. Develop ASC-Optimized Product Portfolios
13.1.2. Reduce Instrument and Sterilization Burden
13.1.3. Expand Flexible Capital Placement Models
13.1.4. Strengthen Reimbursement and Economic Evidence
13.1.5. Build Multi-Site Clinical Support Capabilities
13.2. Recommendations for Ambulatory Surgery Centers
13.2.1. Standardize Implant and Instrument Portfolios
13.2.2. Evaluate Total Procedure Cost
13.2.3. Align Robotics with Sustainable Procedure Volume
13.2.4. Strengthen Patient Selection and Transfer Protocols
13.3. Recommendations for Hospitals and Health Systems
13.3.1. Develop Integrated Inpatient–Outpatient Orthopedic Networks
13.3.2. Align Hospital and ASC Procurement
13.3.3. Protect High-Acuity Capacity Through Site-of-Care Migration
13.3.4. Establish Enterprise Outcomes Measurement
13.4. Recommendations for Orthopedic Physician Groups
13.4.1. Optimize Surgeon Preference Items
13.4.2. Evaluate ASC Ownership and Partnership Models
13.4.3. Standardize Enhanced Recovery Pathways
13.4.4. Use Outcomes Data for Payer Contracting
13.5. Recommendations for Investors and Private Equity Firms
13.5.1. Prioritize High-Growth Orthopedic Procedure Platforms
13.5.2. Evaluate Facility Density and Physician Alignment
13.5.3. Assess Device Contract and Capital Obligations
13.5.4. Identify Regional ASC Expansion Opportunities
13.6. Recommendations for Distributors and Channel Partners
13.6.1. Build Case-Specific Inventory Capabilities
13.6.2. Support Distributed ASC Networks
13.6.3. Expand Sterile-Kit and Logistics Services
13.7. Recommendations for New Entrants and Startups
13.7.1. Target Unresolved Outpatient Workflow Problems
13.7.2. Generate Procedure-Level Economic Evidence
13.7.3. Build Focused Surgeon Education Programs
13.7.4. Pursue Strategic Distribution Partnerships
13.8. Go-to-Market Strategy Considerations
13.8.1. Target-Customer Prioritization
13.8.2. Regional Market Entry
13.8.3. Key Opinion Leader Development
13.8.4. Payer and Employer Engagement
13.8.5. Pricing and Contracting Strategy
13.9. Product Positioning and Portfolio Expansion Guidance
13.9.1. Joint Reconstruction
13.9.2. Sports Medicine
13.9.3. Extremities
13.9.4. Outpatient Spine
13.9.5. Robotics and Navigation
13.9.6. Connected Recovery

What this section provides: This section converts market intelligence into actionable strategies for product development, ASC penetration, contracting, investment decisions, portfolio expansion, and competitive differentiation.

14. U.S. Outpatient Orthopedic Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. State-Level Estimation Limitation
14.6. Procedure-Volume Estimation Limitation
14.7. Regulatory and Reimbursement Limitation
14.8. Company Information Limitation
14.9. Legal Disclaimer
14.10. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s market boundaries, data-use terms, state-level estimation limitations, forecasting assumptions, reimbursement uncertainties, and legal conditions.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Outpatient Orthopedic Devices Market: Market Definition and Scope
TABLE 3: U.S. Outpatient Orthopedic Devices Market: Research Methodology Framework
TABLE 4: U.S. Outpatient Orthopedic Devices Market: Market Sizing and Bottom-Up Procedure Modeling Framework
TABLE 5: U.S. Outpatient Orthopedic Devices Market: Key Assumptions
TABLE 6: U.S. Outpatient Orthopedic Devices Market: Market Ecosystem Overview
TABLE 7: U.S. Outpatient Orthopedic Devices Market: Stakeholder Analysis
TABLE 8: U.S. Outpatient Orthopedic Devices Market: Outpatient Orthopedic Care Pathway
TABLE 9: U.S. Outpatient Orthopedic Devices Market: Executive Summary Snapshot, 2025
TABLE 10: U.S. Outpatient Orthopedic Devices Market: Analyst Viewpoint Summary
TABLE 11: U.S. Outpatient Orthopedic Devices Market: Market Attractiveness Index
TABLE 12: U.S. Outpatient Orthopedic Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 13: U.S. Outpatient Orthopedic Devices Market: Base Year Market Positioning, 2025
TABLE 14: U.S. Outpatient Orthopedic Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 15: U.S. Outpatient Orthopedic Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 16: U.S. Outpatient Orthopedic Devices Market: High-Growth Opportunity Areas
TABLE 17: U.S. Outpatient Orthopedic Devices Market: Drivers; Impact Analysis
TABLE 18: U.S. Outpatient Orthopedic Devices Market: Restraints; Impact Analysis
TABLE 19: U.S. Outpatient Orthopedic Devices Market: Opportunities; Impact Analysis
TABLE 20: U.S. Outpatient Orthopedic Devices Market: Challenges; Impact Analysis
TABLE 21: U.S. Outpatient Orthopedic Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 22: U.S. Outpatient Orthopedic Devices Market: Outpatient Orthopedic Clinical Workflow Economics Matrix
TABLE 23: U.S. Outpatient Orthopedic Devices Market: Orthopedic Capital Procurement Behavior Matrix
TABLE 24: U.S. Outpatient Orthopedic Devices Market: Site-of-Care Migration Analysis
TABLE 25: U.S. Outpatient Orthopedic Devices Market: Patient Selection and Outpatient Eligibility Matrix
TABLE 26: U.S. Outpatient Orthopedic Devices Market: PESTEL Analysis
TABLE 27: U.S. Outpatient Orthopedic Devices Market: Porter’s Five Forces Analysis
TABLE 28: U.S. Outpatient Orthopedic Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 29: U.S. Outpatient Orthopedic Devices Market: Value Chain Analysis
TABLE 30: U.S. Outpatient Orthopedic Devices Market: Supply Chain Analysis
TABLE 31: U.S. Outpatient Orthopedic Devices Market: Digitalization and Connected Orthopedic Care Impact
TABLE 32: U.S. Outpatient Orthopedic Devices Market: Application & Innovation Landscape
TABLE 33: U.S. Outpatient Orthopedic Devices Market: FDA Regulatory Framework Analysis
TABLE 34: U.S. Outpatient Orthopedic Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 35: U.S. Outpatient Orthopedic Devices Market: State Certificate-of-Need and Facility Licensing Analysis
TABLE 36: U.S. Outpatient Orthopedic Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 37: U.S. Outpatient Orthopedic Devices Market: Government Initiatives and Musculoskeletal Health Programs
TABLE 38: U.S. Outpatient Orthopedic Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 39: U.S. Outpatient Orthopedic Devices Market: Orthopedic Value Analysis Committee Decision Framework
TABLE 40: U.S. Outpatient Orthopedic Devices Market: Environmental Sustainability in Orthopedic Device Procurement
TABLE 41: U.S. Outpatient Orthopedic Devices Market: Product Type Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Product Type
TABLE 43: U.S. Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 44: U.S. Outpatient Orthopedic Devices Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 45: U.S. Outpatient Orthopedic Devices Market: Joint Reconstruction Implants Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Outpatient Orthopedic Devices Market: Sports Medicine and Arthroscopy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Outpatient Orthopedic Devices Market: Trauma and Extremity Fixation Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Outpatient Orthopedic Devices Market: Outpatient Spine Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Outpatient Orthopedic Devices Market: Orthobiologics and Regenerative Products Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Outpatient Orthopedic Devices Market: Bracing, Supports and Recovery Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Outpatient Orthopedic Devices Market: Procedure and Application Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by Procedure and Application
TABLE 53: U.S. Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 54: U.S. Outpatient Orthopedic Devices Market: Segment Share Analysis, by Procedure and Application, 2025 & 2035 (%)
TABLE 55: U.S. Outpatient Orthopedic Devices Market: Total Joint Replacement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Outpatient Orthopedic Devices Market: Sports Injury and Soft-Tissue Repair Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Outpatient Orthopedic Devices Market: Fracture and Extremity Reconstruction Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Outpatient Orthopedic Devices Market: Spine and Interventional Musculoskeletal Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Outpatient Orthopedic Devices Market: Hand, Foot, Ankle and Other Orthopedic Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Outpatient Orthopedic Devices Market: Orthopedic Pain Management and Joint Preservation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Outpatient Orthopedic Devices Market: Care Setting Snapshot, 2025
TABLE 62: Segment Dashboard; Definition and Scope, by Care Setting
TABLE 63: U.S. Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 64: U.S. Outpatient Orthopedic Devices Market: Segment Share Analysis, by Care Setting, 2025 & 2035 (%)
TABLE 65: U.S. Outpatient Orthopedic Devices Market: Freestanding Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Outpatient Orthopedic Devices Market: Hospital Outpatient Departments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Outpatient Orthopedic Devices Market: Orthopedic Offices and Specialty Procedure Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Outpatient Orthopedic Devices Market: Outpatient Spine and Pain Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Outpatient Orthopedic Devices Market: Outpatient Rehabilitation and Home Recovery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Outpatient Orthopedic Devices Market: Technology and Workflow Model Snapshot, 2025
TABLE 71: Segment Dashboard; Definition and Scope, by Technology and Workflow Model
TABLE 72: U.S. Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 73: U.S. Outpatient Orthopedic Devices Market: Segment Share Analysis, by Technology and Workflow Model, 2025 & 2035 (%)
TABLE 74: U.S. Outpatient Orthopedic Devices Market: Conventional Implant and Reusable Instrument Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Outpatient Orthopedic Devices Market: Robotic-Assisted Surgery and Navigation Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Outpatient Orthopedic Devices Market: Patient-Specific and Additively Manufactured Solutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Outpatient Orthopedic Devices Market: Single-Use and Reduced-Tray Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Outpatient Orthopedic Devices Market: Connected and Data-Enabled Orthopedic Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Outpatient Orthopedic Devices Market: Procurement Channel Snapshot, 2025
TABLE 80: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 81: U.S. Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 82: U.S. Outpatient Orthopedic Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 83: U.S. Outpatient Orthopedic Devices Market: Direct ASC and Orthopedic Group Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Outpatient Orthopedic Devices Market: Hospital and Integrated Delivery Network Outpatient Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Outpatient Orthopedic Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Outpatient Orthopedic Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Outpatient Orthopedic Devices Market: Capital Equipment and Technology Procurement Models Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: U.S. Outpatient Orthopedic Devices Market: Regional Snapshot, 2025
TABLE 89: Segment Dashboard; Definition and Scope, by Geography
TABLE 90: U.S. Outpatient Orthopedic Devices Market, by Geography, 2021–2035 (US$ Billion)
TABLE 91: U.S. Outpatient Orthopedic Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 92: U.S. Outpatient Orthopedic Devices Market: Regional Outpatient Orthopedic Procedure Volume and ASC Infrastructure Analysis
TABLE 93: U.S. Outpatient Orthopedic Devices Market: Regional Reimbursement, Site-of-Care and Procurement Dynamics
TABLE 94: West Region U.S. Outpatient Orthopedic Devices Market: Regional Overview and Trends
TABLE 95: West Region U.S. Outpatient Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 96: West Region U.S. Outpatient Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 99: West Region U.S. Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 100: West Region U.S. Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 101: West Region U.S. Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 102: California Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 103: California Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 104: California Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 105: California Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 106: California Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 107: Washington Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 108: Washington Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 109: Washington Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 110: Washington Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 111: Washington Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 112: Arizona Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 113: Arizona Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 114: Arizona Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 115: Arizona Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 116: Arizona Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 117: Colorado Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 118: Colorado Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 119: Colorado Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 120: Colorado Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 121: Colorado Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 122: Oregon Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 123: Oregon Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 124: Oregon Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 125: Oregon Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 126: Oregon Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 127: Utah Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 128: Utah Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 129: Utah Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 130: Utah Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 131: Utah Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 132: Nevada Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 133: Nevada Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 134: Nevada Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 135: Nevada Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 136: Nevada Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 137: New Mexico Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 138: New Mexico Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 139: New Mexico Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 140: New Mexico Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 141: New Mexico Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 142: Idaho Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 143: Idaho Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 144: Idaho Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 145: Idaho Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 146: Idaho Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 147: Montana Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 148: Montana Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 149: Montana Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 150: Montana Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 151: Montana Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 152: Wyoming Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 153: Wyoming Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 154: Wyoming Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 155: Wyoming Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 156: Wyoming Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 157: Alaska Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 158: Alaska Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 159: Alaska Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 160: Alaska Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 161: Alaska Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 162: Hawaii Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 163: Hawaii Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 164: Hawaii Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 165: Hawaii Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 166: Hawaii Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Outpatient Orthopedic Devices Market: Regional Overview and Trends
TABLE 168: Northeast Region U.S. Outpatient Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 169: Northeast Region U.S. Outpatient Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 171: Northeast Region U.S. Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 172: Northeast Region U.S. Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 173: Northeast Region U.S. Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 174: Northeast Region U.S. Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 175: New York Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 176: New York Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 177: New York Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 178: New York Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 179: New York Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 181: Massachusetts Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 182: Massachusetts Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 183: Massachusetts Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 184: Massachusetts Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 185: New Jersey Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 186: New Jersey Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 187: New Jersey Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 188: New Jersey Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 189: New Jersey Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 191: Pennsylvania Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 192: Pennsylvania Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 193: Pennsylvania Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 194: Pennsylvania Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 195: Connecticut Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 196: Connecticut Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 197: Connecticut Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 198: Connecticut Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 199: Connecticut Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 200: Maine Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 201: Maine Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 202: Maine Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 203: Maine Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 204: Maine Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 205: Vermont Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 206: Vermont Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 207: Vermont Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 208: Vermont Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 209: Vermont Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 211: New Hampshire Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 212: New Hampshire Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 213: New Hampshire Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 214: New Hampshire Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 216: Rhode Island Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 217: Rhode Island Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 218: Rhode Island Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 219: Rhode Island Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Outpatient Orthopedic Devices Market: Regional Overview and Trends
TABLE 221: South Region U.S. Outpatient Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 222: South Region U.S. Outpatient Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 223: South Region U.S. Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 224: South Region U.S. Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 228: Texas Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 229: Texas Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 230: Texas Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 231: Texas Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 232: Texas Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 233: Florida Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 234: Florida Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 235: Florida Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 236: Florida Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 237: Florida Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 238: Georgia Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 239: Georgia Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 240: Georgia Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 241: Georgia Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 242: Georgia Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 243: North Carolina Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 244: North Carolina Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 247: North Carolina Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 248: Tennessee Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 249: Tennessee Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 252: Tennessee Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 253: South Carolina Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 254: South Carolina Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 257: South Carolina Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 258: Alabama Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 259: Alabama Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 260: Alabama Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 261: Alabama Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 262: Alabama Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 263: Mississippi Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 264: Mississippi Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 267: Mississippi Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 268: Louisiana Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 269: Louisiana Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 272: Louisiana Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 273: Arkansas Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 274: Arkansas Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 277: Arkansas Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 278: Kentucky Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 279: Kentucky Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 282: Kentucky Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 283: Oklahoma Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 284: Oklahoma Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 288: Virginia Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 289: Virginia Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 290: Virginia Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 291: Virginia Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 292: Virginia Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 293: Maryland Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 294: Maryland Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 295: Maryland Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 296: Maryland Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 297: Maryland Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 298: West Virginia Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 299: West Virginia Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 302: West Virginia Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 303: Delaware Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 304: Delaware Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 305: Delaware Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 306: Delaware Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 307: Delaware Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 308: District of Columbia Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 309: District of Columbia Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 310: District of Columbia Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 311: District of Columbia Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 312: District of Columbia Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 313: Midwest Region U.S. Outpatient Orthopedic Devices Market: Regional Overview and Trends
TABLE 314: Midwest Region U.S. Outpatient Orthopedic Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 315: Midwest Region U.S. Outpatient Orthopedic Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 316: Midwest Region U.S. Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 317: Midwest Region U.S. Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 318: Midwest Region U.S. Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 319: Midwest Region U.S. Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 320: Midwest Region U.S. Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 321: Illinois Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 322: Illinois Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 323: Illinois Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 324: Illinois Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 325: Illinois Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 326: Ohio Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 327: Ohio Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 328: Ohio Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 329: Ohio Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 330: Ohio Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 331: Michigan Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 332: Michigan Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 333: Michigan Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 334: Michigan Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 335: Michigan Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 336: Minnesota Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 337: Minnesota Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 338: Minnesota Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 339: Minnesota Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 340: Minnesota Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 341: Indiana Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 342: Indiana Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 343: Indiana Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 344: Indiana Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 345: Indiana Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 346: Wisconsin Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 347: Wisconsin Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 348: Wisconsin Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 349: Wisconsin Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 350: Wisconsin Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 351: Missouri Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 352: Missouri Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 353: Missouri Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 354: Missouri Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 355: Missouri Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 356: Iowa Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 357: Iowa Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 358: Iowa Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 359: Iowa Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 360: Iowa Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 361: Kansas Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 362: Kansas Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 363: Kansas Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 364: Kansas Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 365: Kansas Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 366: Nebraska Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 367: Nebraska Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 368: Nebraska Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 369: Nebraska Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 370: Nebraska Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 371: North Dakota Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 372: North Dakota Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 373: North Dakota Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 374: North Dakota Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 375: North Dakota Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 376: South Dakota Outpatient Orthopedic Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 377: South Dakota Outpatient Orthopedic Devices Market, by Procedure and Application, 2021–2035 (US$ Billion)
TABLE 378: South Dakota Outpatient Orthopedic Devices Market, by Care Setting, 2021–2035 (US$ Billion)
TABLE 379: South Dakota Outpatient Orthopedic Devices Market, by Technology and Workflow Model, 2021–2035 (US$ Billion)
TABLE 380: South Dakota Outpatient Orthopedic Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 381: U.S. Outpatient Orthopedic Devices Market: Competitive Landscape Snapshot, 2025
TABLE 382: U.S. Outpatient Orthopedic Devices Market: Key Company Market Share Analysis, 2025
TABLE 383: U.S. Outpatient Orthopedic Devices Market: Market Share Analysis by Product Category, 2025
TABLE 384: U.S. Outpatient Orthopedic Devices Market: Company Positioning Matrix
TABLE 385: U.S. Outpatient Orthopedic Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 386: U.S. Outpatient Orthopedic Devices Market: ASC-Specific Commercial Strategy Benchmarking
TABLE 387: U.S. Outpatient Orthopedic Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 388: Stryker Corporation: Company Profile
TABLE 389: Zimmer Biomet Holdings: Company Profile
TABLE 390: DePuy Synthes, Johnson & Johnson MedTech: Company Profile
TABLE 391: Smith+Nephew: Company Profile
TABLE 392: Arthrex: Company Profile
TABLE 393: Medtronic: Company Profile
TABLE 394: Globus Medical: Company Profile
TABLE 395: Enovis Corporation: Company Profile
TABLE 396: CONMED Corporation: Company Profile
TABLE 397: Integra LifeSciences: Company Profile
TABLE 398: Orthofix Medical: Company Profile
TABLE 399: Exactech: Company Profile
TABLE 400: Alphatec Holdings: Company Profile
TABLE 401: ZimVie: Company Profile
TABLE 402: Acumed: Company Profile
TABLE 403: MicroPort Orthopedics: Company Profile
TABLE 404: SI-BONE: Company Profile
TABLE 405: Treace Medical Concepts: Company Profile
TABLE 406: restor3d: Company Profile
TABLE 407: Anika Therapeutics: Company Profile
TABLE 408: Bioventus: Company Profile
TABLE 409: Össur: Company Profile
TABLE 410: Breg: Company Profile
TABLE 411: Aspen Medical Products: Company Profile
TABLE 412: OrthoPediatrics: Company Profile
TABLE 413: U.S. Outpatient Orthopedic Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 414: U.S. Outpatient Orthopedic Devices Market: Disruptive Technologies Impact Matrix
TABLE 415: U.S. Outpatient Orthopedic Devices Market: Emerging Business Trends
TABLE 416: U.S. Outpatient Orthopedic Devices Market: Business Opportunities for Startups and Existing Players
TABLE 417: U.S. Outpatient Orthopedic Devices Market: Investment Prioritization Matrix
TABLE 418: U.S. Outpatient Orthopedic Devices Market: Forecast Sensitivity Analysis
TABLE 419: U.S. Outpatient Orthopedic Devices Market: Strategic Recommendations for Orthopedic Device Manufacturers
TABLE 420: U.S. Outpatient Orthopedic Devices Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 421: U.S. Outpatient Orthopedic Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 422: U.S. Outpatient Orthopedic Devices Market: Strategic Recommendations for Orthopedic Physician Groups
TABLE 423: U.S. Outpatient Orthopedic Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 424: U.S. Outpatient Orthopedic Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 425: U.S. Outpatient Orthopedic Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 426: U.S. Outpatient Orthopedic Devices Market: Go-to-Market Strategy Considerations
TABLE 427: U.S. Outpatient Orthopedic Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 428: U.S. Outpatient Orthopedic Devices Market: Scope Limitation
TABLE 429: U.S. Outpatient Orthopedic Devices Market: Market Definition Limitation
TABLE 430: U.S. Outpatient Orthopedic Devices Market: Data Use Limitation
TABLE 431: U.S. Outpatient Orthopedic Devices Market: Forecasting Limitation
TABLE 432: U.S. Outpatient Orthopedic Devices Market: State-Level Estimation Limitation
TABLE 433: U.S. Outpatient Orthopedic Devices Market: Procedure-Volume Estimation Limitation
TABLE 434: U.S. Outpatient Orthopedic Devices Market: Regulatory and Reimbursement Limitation
TABLE 435: U.S. Outpatient Orthopedic Devices Market: Company Information Limitation
TABLE 436: U.S. Outpatient Orthopedic Devices Market: Legal Disclaimer
TABLE 437: U.S. Outpatient Orthopedic Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Outpatient Orthopedic Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Sizing and Validation Framework
FIGURE 4: U.S. Outpatient Orthopedic Care Pathway
FIGURE 5: Market Ecosystem and Stakeholder Map
FIGURE 6: Value Chain Analysis
FIGURE 7: Supply Chain Analysis
FIGURE 8: PESTEL Analysis
FIGURE 9: Porter’s Five Forces Analysis
FIGURE 10: Market Attractiveness Analysis
FIGURE 11: Market Dynamics
FIGURE 12: Innovation & Patent Landscape, 2021–2025
FIGURE 13: Outpatient Orthopedic Clinical Workflow Economics Framework
FIGURE 14: Orthopedic Capital Procurement Decision Framework
FIGURE 15: Site-of-Care Migration Framework
FIGURE 16: Patient Selection and Outpatient Eligibility Framework
FIGURE 17: U.S. Outpatient Orthopedic Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 18: U.S. Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 19: U.S. Outpatient Orthopedic Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 20: FDA Regulatory and CMS Reimbursement Framework
FIGURE 21: State Certificate-of-Need and Facility Development Landscape
FIGURE 22: Orthopedic Value Analysis Committee Decision Framework
FIGURE 23: Environmental Sustainability in Orthopedic Device Procurement
FIGURE 24: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Joint Reconstruction Implants Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Sports Medicine and Arthroscopy Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Trauma and Extremity Fixation Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Outpatient Spine Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Orthobiologics and Regenerative Products Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Bracing, Supports and Recovery Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Procedure and Application Segment Market Share Analysis, 2025 & 2035
FIGURE 33: Procedure and Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Total Joint Replacement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Sports Injury and Soft-Tissue Repair Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Fracture and Extremity Reconstruction Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Spine and Interventional Musculoskeletal Care Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Hand, Foot, Ankle and Other Orthopedic Procedures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Orthopedic Pain Management and Joint Preservation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Care Setting Segment Market Share Analysis, 2025 & 2035
FIGURE 41: Care Setting Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Freestanding Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Hospital Outpatient Departments Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Orthopedic Offices and Specialty Procedure Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Outpatient Spine and Pain Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Outpatient Rehabilitation and Home Recovery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Technology and Workflow Model Segment Market Share Analysis, 2025 & 2035
FIGURE 48: Technology and Workflow Model Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Conventional Implant and Reusable Instrument Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Robotic-Assisted Surgery and Navigation Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Patient-Specific and Additively Manufactured Solutions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Single-Use and Reduced-Tray Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Connected and Data-Enabled Orthopedic Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Direct ASC and Orthopedic Group Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Hospital and Integrated Delivery Network Outpatient Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Capital Equipment and Technology Procurement Models Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 62: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Regional Outpatient Orthopedic Procedure Volume and ASC Infrastructure Map
FIGURE 64: West Region U.S. Outpatient Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 65: West Region Market Share Analysis by State, 2025
FIGURE 66: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: California Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Washington Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Arizona Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Colorado Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Oregon Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Utah Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Nevada Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: New Mexico Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Idaho Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Montana Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Wyoming Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Alaska Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Hawaii Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Northeast Region U.S. Outpatient Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 81: Northeast Region Market Share Analysis by State, 2025
FIGURE 82: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: New York Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Massachusetts Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: New Jersey Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Pennsylvania Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Connecticut Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Maine Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Vermont Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: New Hampshire Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Rhode Island Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: South Region U.S. Outpatient Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 93: South Region Market Share Analysis by State, 2025
FIGURE 94: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Texas Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Florida Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Georgia Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: North Carolina Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Tennessee Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: South Carolina Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Alabama Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Mississippi Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Louisiana Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Arkansas Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Kentucky Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Oklahoma Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Virginia Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Maryland Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: West Virginia Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Delaware Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: District of Columbia Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Midwest Region U.S. Outpatient Orthopedic Devices Market Share and Leading Players, 2025
FIGURE 113: Midwest Region Market Share Analysis by State, 2025
FIGURE 114: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Illinois Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Ohio Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Michigan Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Minnesota Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: Indiana Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Wisconsin Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: Missouri Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 122: Iowa Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 123: Kansas Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 124: Nebraska Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 125: North Dakota Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 126: South Dakota Outpatient Orthopedic Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 127: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 128: Company Positioning Matrix
FIGURE 129: Key Player Product Portfolio Benchmarking
FIGURE 130: ASC-Specific Commercial Strategy Benchmarking
FIGURE 131: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 132: Outpatient Orthopedic Device Innovation Roadmap
FIGURE 133: ASC-Oriented Robotic Surgery Adoption Roadmap
FIGURE 134: Patient-Specific and Additively Manufactured Device Opportunity Map
FIGURE 135: Single-Use and Reduced-Tray Technology Growth Roadmap
FIGURE 136: Connected Orthopedic Recovery Growth Roadmap
FIGURE 137: Future Market Scenario Analysis, 2026–2035
FIGURE 138: Disruptive Technologies Impact Matrix
FIGURE 139: Emerging Business Trends Matrix
FIGURE 140: Investment Prioritization Matrix
FIGURE 141: Forecast Sensitivity Analysis
FIGURE 142: Strategic Growth Roadmap for U.S. Outpatient Orthopedic Device Companies
FIGURE 143: Go-to-Market Strategy Framework
FIGURE 144: Product Positioning and Portfolio Expansion Framework
FIGURE 145: Report Scope and Disclaimer Framework